| Year |
Citation |
Score |
| 2024 |
Zhang Q, Li Z, Li Q, Trammell SA, Schmidt MS, Pires KM, Cai J, Zhang Y, Kenny H, Boudina S, Brenner C, Abel ED. Control of NAD homeostasis by autophagic flux modulates mitochondrial and cardiac function. The Embo Journal. PMID 38212381 DOI: 10.1038/s44318-023-00009-w |
0.428 |
|
| 2020 |
Heer CD, Sanderson DJ, Voth LS, Alhammad YMO, Schmidt MS, Trammell SAJ, Perlman S, Cohen MS, Fehr AR, Brenner C. Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity. The Journal of Biological Chemistry. PMID 33051211 DOI: 10.1074/jbc.RA120.015138 |
0.474 |
|
| 2020 |
Heer CD, Sanderson DJ, Alhammad YMO, Schmidt MS, Trammell SAJ, Perlman S, Cohen MS, Fehr AR, Brenner C. Coronavirus and PARP expression dysregulate the NAD Metabolome: a potentially actionable component of innate immunity. Biorxiv : the Preprint Server For Biology. PMID 32511303 DOI: 10.1101/2020.04.17.047480 |
0.433 |
|
| 2017 |
Diguet N, Trammell SAJ, Tannous C, Deloux R, Piquereau J, Mougenot N, Gouge A, Gressette M, Manoury B, Blanc J, Breton M, Decaux JF, Lavery G, Baczkó I, Zoll J, et al. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. Circulation. PMID 29217642 DOI: 10.1161/Circulationaha.116.026099 |
0.46 |
|
| 2017 |
Wilsbacher JL, Cheng M, Cheng D, Trammell SAJ, Shi Y, Guo J, Koeniger SL, Kovar PJ, He Y, Selvaraju S, Heyman HR, Sorensen BK, Clark RF, Hansen TM, Longenecker KL, et al. Discovery and Characterization of Novel Non-substrate and Substrate NAMPT Inhibitors. Molecular Cancer Therapeutics. PMID 28468779 DOI: 10.1158/1535-7163.Mct-16-0819 |
0.481 |
|
| 2016 |
Ratajczak J, Joffraud M, Trammell SA, Ras R, Canela N, Boutant M, Kulkarni SS, Rodrigues M, Redpath P, Migaud ME, Auwerx J, Yanes O, Brenner C, Cantó C. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications. 7: 13103. PMID 27725675 DOI: 10.1038/Ncomms13103 |
0.497 |
|
| 2016 |
Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li Z, Abel ED, Migaud ME, Brenner C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications. 7: 12948. PMID 27721479 DOI: 10.1038/Ncomms12948 |
0.427 |
|
| 2016 |
Trammell SA, Weidemann BJ, Chadda A, Yorek MS, Holmes A, Coppey LJ, Obrosov A, Kardon RH, Yorek MA, Brenner C. Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Scientific Reports. 6: 26933. PMID 27230286 DOI: 10.1038/Srep26933 |
0.406 |
|
| 2016 |
Trammell SA, Yu L, Redpath P, Migaud ME, Brenner C. Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk. The Journal of Nutrition. PMID 27052539 DOI: 10.3945/Jn.116.230078 |
0.41 |
|
| 2015 |
Trammell SA, Brenner C. NNMT: A Bad Actor in Fat Makes Good in Liver. Cell Metabolism. 22: 200-1. PMID 26244929 DOI: 10.1016/J.Cmet.2015.07.017 |
0.402 |
|
| 2013 |
Trammell SA, Brenner C. Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites. Computational and Structural Biotechnology Journal. 4: e201301012. PMID 24688693 DOI: 10.5936/Csbj.201301012 |
0.451 |
|
| 2012 |
Midtkandal RR, Redpath P, Trammell SA, Macdonald SJ, Brenner C, Migaud ME. Novel synthetic route to the C-nucleoside, 2-deoxy benzamide riboside. Bioorganic & Medicinal Chemistry Letters. 22: 5204-7. PMID 22795628 DOI: 10.1016/J.Bmcl.2012.06.069 |
0.376 |
|
| Show low-probability matches. |